NEW YORK (GenomeWeb News) – Isogenica today said it has received a three-year, €700,000 ($909,249) grant as part of a project to develop a system for the "deep" screening of peptide libraries against therapeutic targets.
The funding to Isogenica is through the European Commission's Seventh Framework Programme and is part of a €5.5 million project with consortium grant funding of about €4 million. The grant began in January.
Isogenica will combine its CIS display techniques with high-throughput sequencing to screen hundreds of trillions of peptides and to identify up to 100,000 peptide hits against target proteins, the Cambridge, UK-based firm said.
Other members of the project include Apogenix; Biametrics; the Center for Advanced Bioanalysis; the German Cancer Research Centre; the Karlsruher Institute for Technology; Microsystems; PepPerPrint; the Technical University of Varna; and the MRC Weatherall Institute of Molecular Medicine at the University of Oxford.